LEO Pharma Overview
- Year Founded
-
1908
- Status
-
IPO Registration
- Employees
-
4,400
- Latest Deal Type
-
IPO
- (Announced)
- Financing Rounds
-
6
- Investments
-
14
LEO Pharma General Information
Description
Manufacturer of medicines intended to treat skin diseases based in Ballerup, Denmark. The company offers dermatology medication and a wide range of therapies, providing patients with safe and effective treatment.
Contact Information
Website
www.leo-pharma.comCorporate Office
- Industriparken 55
- 2750 Ballerup
- Denmark
Corporate Office
- Industriparken 55
- 2750 Ballerup
- Denmark
LEO Pharma Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
LEO Pharma Comparisons
Industry
Financing
Details
LEO Pharma Competitors (90)
One of LEO Pharma’s 90 competitors is Ferrer Internacional, a Private Debt Financed company based in Barcelona, Spain.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Ferrer Internacional | Private Debt Financed | Barcelona, Spain | ||||
| The Zambon Group | Private Debt Financed | Bresso, Italy | ||||
| Renova Therapeutics | Venture Capital-Backed | Carlsbad, CA | ||||
| MC2 Therapeutics | Corporation | Horsholm, Denmark | ||||
| Alvogen Group | Formerly PE-Backed | Morristown, NJ |
LEO Pharma Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
LEO Pharma Patents
LEO Pharma Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026224409-A1 | Use of delgocitinib for the treatment of palmoplantar pustulosis | Pending | 25-Apr-2025 | ||
| US-20250340551-A1 | Small molecule modulators of stat6 | Pending | 27-Mar-2024 | ||
| US-20260001893-A1 | Small molecule modulators of stat6 | Pending | 27-Mar-2024 | ||
| US-20250320205-A1 | Stat6 degraders | Pending | 27-Mar-2024 | ||
| US-20250320206-A1 | Stat6 degraders | Pending | 27-Mar-2024 | C07D471/04 |
LEO Pharma Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
LEO Pharma Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
LEO Pharma Investments & Acquisitions (14)
LEO Pharma’s most recent deal was a Buyout/LBO with Tanabe Pharma (Worldwide Rights to Dersimelagon) for . The deal was made on 18-Sep-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Tanabe Pharma (Worldwide Rights to Dersimelagon) | 18-Sep-2026 | Buyout/LBO | Buildings and Property | ||
| Replay (Drug Discovery) | 30-Apr-2026 | Buyout/LBO | Drug Discovery | ||
| Trex Wind Down | 01-Dec-2023 | Buyout/LBO | Pharmaceuticals | ||
| Bayer (dermatology business) | 01-Jul-2019 | Merger/Acquisition | Pharmaceuticals | ||
| Gore Range Capital | 04-Feb-2019 | Corporate | Private Equity |
LEO Pharma Exits (4)
LEO Pharma’s most recent exit was on 06-Apr-2018 from Naked Biome. The exit was categorized as with 2 buyers.
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Naked Biome | 06-Apr-2018 | Completed |
|
||
| Novopyxis | 21-Jul-2017 | Completed |
|
||
| FB Dermatology (Acquired) | 01-Mar-2017 | Completed |
|
||
| LiPlasome Pharma | 19-Jan-2001 | Early Stage VC | Completed |
|
LEO Pharma Affiliates
Subsidiaries (5)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| LEO Pharma (Pharmaceuticals) | Vienna, Austria | 1997 | |
| Wexport | Cork, Ireland | 1978 | |
| Leo Laboratories | Maidenhead, United Kingdom | 1960 | |
| Løvens Kemiske Fabriks Handelsaktieselskab | Ballerup, Denmark | 1951 | |
| LEO Pharma Retirement Benefits Plan | Ballerup, Denmark |
LEO Pharma FAQs
-
When was LEO Pharma founded?
LEO Pharma was founded in 1908.
-
Where is LEO Pharma headquartered?
LEO Pharma is headquartered in Ballerup, Denmark.
-
What is the size of LEO Pharma?
LEO Pharma has 4,400 total employees.
-
What industry is LEO Pharma in?
LEO Pharma’s primary industry is Pharmaceuticals.
-
Is LEO Pharma a private or public company?
LEO Pharma is a Private company.
-
What is LEO Pharma’s current revenue?
The current revenue for LEO Pharma is .
-
How much funding has LEO Pharma raised over time?
LEO Pharma has raised $2.51B.
-
Who are LEO Pharma’s investors?
Nordic Capital has invested in LEO Pharma.
-
Who are LEO Pharma’s competitors?
Ferrer Internacional, The Zambon Group, Renova Therapeutics, MC2 Therapeutics, and Alvogen Group are some of the 90 competitors of LEO Pharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
